| [1] |
万舰,王永南,韩晓蓉,等.前哨淋巴结阳性乳腺癌患者的临床病理特征与非前哨淋巴结转移的关系[J/CD]. 中华乳腺病杂志(电子版),2015,9(2):101-105.
|
| [2] |
Gould EA, Winship T, Philbin PH, et al. Observations on a “sentinel node” in cancer of the parotid [J].Cancer,1960,13:77-78.
|
| [3] |
Fleissig A,Fallowfield LJ,Langridge CI, et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer [J]. Breast Cancer Res Treat,2006,95(3):279-293.
|
| [4] |
Krag DN, Anderson SJ, Julian TB, et al. Sentinel lymph node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933.
|
| [5] |
罗舟,徐涛,秦建伟.前哨淋巴结活组织检查指导乳腺癌腋窝淋巴结清扫问题的思考[J/CD]. 中华乳腺病杂志(电子版),2014,8(1):61-64.
|
| [6] |
Giuliano AE,McCall L,Beitsch P,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial [J]. Ann Surg,2010,252(3):426-432.
|
| [7] |
Sinn HP, Helmchen B, Wittekind CH. TNM classification of breast cancer: changes and comments on the 7th edition[J]. Pathologe,2010,31(5):361-366.
|
| [8] |
Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305.
|
| [9] |
Cserni G, Gregori D, Merletti F, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer[J]. Br J Surg,2004,91(10):1245-1252.
|
| [10] |
Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer [J]. J Am Coll Surg,2008,206(2):261-268.
|
| [11] |
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015 版)[J]. 中国癌症杂志,2015(9):692-754.
|
| [12] |
Güth U, Myrick ME, Viehl CT, et al. The post ACOSOG Z0011 era:does our new understanding of breast cancer really change clinical practice? [J]. Eur J Surg Oncol,2012,38(8):645-650.
|
| [13] |
刘淼,王殊,彭媛,等. ACOSOG Z0011 试验标准用于中国前哨淋巴结阳性乳腺癌患者以避免腋窝淋巴结清扫的可行性研究[J]. 中国癌症杂志,2015,25(2):135-140.
|
| [14] |
Yang B, Yang L, Zuo WS, et al. Predictors to assess non-sentinel lymph node status in breast cancer patients with only one sentinel lymph node metastasis [J].Chin Med J (Engl),2013,126(3):476-481.
|
| [15] |
Eldweny H, Alkhaldy K, Alsaleh N, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (pilot study) [J]. J Egypt Natl Canc Inst,2012,24(1):23-30.
|
| [16] |
Bundred NJ, Barnes NL, Rutgers E, et al. Is axillary lymph node clearance required in node-positive breast cancer? [J]. Nat Rev Clin Oncol,2015,12(1):55-61.
|
| [17] |
Gooch J, King TA, Eaton A, et al. The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer[J]. Ann Surg Oncol,2014,21(9):2897-2903.
|
| [18] |
Yajima R,Fujii T,Yanagita Y,et al. Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer[J]. Ann Surg Oncol,2015,22(1):52-58.
|
| [19] |
Hetelekidis S, Schnitt SJ, Silver B, et al. The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer[J].Int J Radiat Oncol Biol Phys,2000,46(1):31-34.
|
| [20] |
Shigematsu H, Taguchi K, Koui H, et al. Clinical significance of extracapsular invasion at sentinel lymph nodes in breast cancer patients with sentinel lymph node involvement [J]. Ann Surg Oncol,2015,22(7):2365-2371.
|
| [21] |
Donker M, Straver ME, van Tienhoven G, et al. Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS trial:identification rate and nodal outcome[J]. Eur J Cancer,2013,49(9):2093-2100.
|
| [22] |
Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy(SENTINA): a prospective, multicentre cohort study[J]. Lancet Oncol,2013,14(7):609-618.
|
| [23] |
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial [J].JAMA,2013,310(14):1455-1461.
|
| [24] |
Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes:implementation of targeted axillary dissection [J]. J Clin Oncol,2016,34(10):1072-1078.
|
| [25] |
Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure [J].Ann Surg,2015,261(2):378-382.
|
| [26] |
National Surgical Adjuvant Breast and Bowel Project. A randomized phase III clinical trial evaluating post-mastectomy chestwall and regional nodal XRT and post-lumpectomy regional nodal XRT in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy[EB/OL]. [2016-02-10].http:/ /www.nsabp.pitt.edu/B-51.asp.
|
| [27] |
Memorial Sloan Kettering Cancer Center. Pre-operative, single-dose ipilimumab and/or cryoablation in early stage/resectable breast cancer[EB/OL]. [2016-02-10]. https:/ /www.clinicaltrials.gov/ct2/show/NCT01502592? term=NCT01502592&rank=1/NCT01502592.
|